BASEL, Switzerland--(BUSINESS WIRE)--LESSENGERS Inc. (�LESSENGERS�), an innovative optical interconnect solution provider, announced today, a live demonstration of polymer-wired 800G QSFP-DD…
DUBLIN--(BUSINESS WIRE)--The "India Over The Counter Drug Market, By Product Type, By Route of Administration, By Dosage Form, By Distribution…
Acquisition of cloud-native payments technology firm to modernize infrastructure and create greater flexibility for the firm�s merchant acquiring capabilities globally…
Celregen Obtains the Exclusive Rights to Develop, Manufacturing and Commercialize CLS001 in Greater China Region; Cellusion Retains Other Regional Rights.…
WUHU, China--(BUSINESS WIRE)--China celebrates the Mid-Autumn Festival on September 10. On this day, all Chinese families will partake in eating…
Extended follow-up data from phase 1/2 trial of DS-7300 in patients with metastatic lung, prostate or esophageal cancer to be…
Tislelizumab demonstrated non-inferiority for overall survival and favorable safety profile versus sorafenib in global Phase 3 trial Additional poster presentations…